New registry aims to uncover gender gaps in heart valve care
NCT ID NCT07196930
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This registry will track 800 adults with valvular heart disease to see if women and men receive different diagnosis, treatment, and follow-up care. Researchers will compare how quickly each group gets guideline-recommended therapies and whether gender, age, or ethnicity affect outcomes. The goal is to identify and reduce unfair disparities in heart valve disease management.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could highlight gaps in care for women with valve disease and guide fairer treatment guidelines.
- What could go wrong
- This is an observational registry, not a treatment trial. It can show patterns but cannot prove what causes them or improve care directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISPARITIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aswan Heart Centre
RECRUITINGAswān, Egypt
-
University of Lisbon
RECRUITINGLisbon, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could skipping the breathing tube speed heart surgery recovery?
- Heart failure care gets a Check-Up: study tests if sharing guidelines boosts treatment
- Heart pressure check during common procedure could unmask hidden heart failure
- Nursing home physiotherapy under the microscope: are guidelines being followed?
- New heart camera aims to make procedures safer
- Hospital tests if its own anemia rules actually get followed